Copyright
©2011 Baishideng Publishing Group Co.
World J Cardiol. Nov 26, 2011; 3(11): 367-373
Published online Nov 26, 2011. doi: 10.4330/wjc.v3.i11.367
Published online Nov 26, 2011. doi: 10.4330/wjc.v3.i11.367
Table 1 Charlson comorbidity index components and weights
| Comorbid condition | Weight |
| Myocardial infarction | 1 |
| Congestive heart failure | 1 |
| Peripheral vascular disease | 1 |
| Cerebrovascular disease | 1 |
| Dementia | 1 |
| Chronic pulmonary disease | 1 |
| Connective tissue disease | 1 |
| Ulcer disease | 1 |
| Mild liver disease | 1 |
| Diabetes | 1 |
| Hemiplegia | 2 |
| Moderate or severe renal disease | 2 |
| Diabetes with end-organ damage | 2 |
| Any tumor | 2 |
| Leukemia | 2 |
| Lymphoma | 2 |
| Moderate or severe liver disease | 3 |
| Metastatic solid tumor | 6 |
| AIDS | 6 |
- Citation: Brugaletta S, Martin-Yuste V, Ferreira-González I, Cola C, Alvarez-Contreras L, Antonio MD, Garcia-Moll X, García-Picart J, Martí V, Balcells-Iranzo J, Sabaté M. Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention. World J Cardiol 2011; 3(11): 367-373
- URL: https://www.wjgnet.com/1949-8462/full/v3/i11/367.htm
- DOI: https://dx.doi.org/10.4330/wjc.v3.i11.367